Package 45802-044-75

{"route": ["TOPICAL"], "spl_id": "02b3e4ad-6b52-4766-99fb-3edd6119c9b9", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["141859"], "spl_set_id": ["63fadf54-e8a3-4512-8a05-d64b998f5a08"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (45802-044-75)  / 5 g in 1 TUBE", "package_ndc": "45802-044-75", "marketing_start_date": "20190211"}], "brand_name": "Acyclovir", "product_id": "45802-044_02b3e4ad-6b52-4766-99fb-3edd6119c9b9", "dosage_form": "CREAM", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "45802-044", "generic_name": "Acyclovir", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "50 mg/g"}], "application_number": "ANDA208702", "marketing_category": "ANDA", "marketing_start_date": "20190211", "listing_expiration_date": "20261231"}